Routine HIV Screening for Herpes Zoster Eye Disease
-
By
-
Ahmed Bakr
-
Navid Hakim
-
Paul Hine
-
Nardine Menassa
-
Nima Ghadiri
-
November 18, 2026
Clinical Scorecard: Routine HIV Screening for Herpes Zoster Eye Disease
At a Glance
| Category | Detail |
|---|---|
| Condition | Herpes zoster ophthalmicus (HZO) and varicella zoster virus (VZV) keratitis; the article’s focus is offering HIV testing when either is suspected. |
| Key Mechanisms | The article states that VZV reactivation signifies impaired cell-mediated immunity and that herpes zoster is an HIV indicator condition associated with undiagnosed HIV. |
| Target Population | Patients presenting with suspected HZO or VZV keratitis; the authors recommend offering HIV testing regardless of age. |
| Care Setting | Ophthalmic clinics and units diagnosing, investigating, or treating HZO or VZV keratitis. |
Key Highlights
- The authors recommend offering HIV testing at the initial presentation of suspected HZO or VZV keratitis, before microbiological confirmation.
- The authors recommend treating a VZV swab request as a prompt to offer HIV testing, with a brief explanation and an opportunity to opt out.
- The authors state that age should not determine whether testing is offered; older adults account for an increasing proportion of new HIV diagnoses.
- The article says severe or atypical ocular complications, including acute retinal necrosis and progressive outer retinal necrosis, should prompt suspicion of underlying immunosuppression.
- The article reports no UK ophthalmology-specific guidance or standardised pathway for HIV testing in HZO or VZV keratitis.
Guideline-Based Recommendations
Diagnosis
- The authors recommend offering HIV testing to every patient with suspected HZO or VZV keratitis, regardless of age and before VZV test confirmation.
- NICE guideline NG60 advises offering and recommending an HIV test to everyone attending for testing or treatment.
- NICE advises testing all adults in high-prevalence areas (2 to 5 diagnosed cases per 1000 people aged 15 to 59) and extremely high-prevalence areas (5 or more per 1000).
Management
- The article recommends offering HIV testing when collecting a VZV viral swab, using a standard explanation and allowing the patient to opt out.
- The article suggests considering a pathway for confirmed positive VZV swab results through local laboratory or clinic reporting systems.
- The article recommends knowing local procedures for fourth-generation serology or point-of-care testing, including test requests and result-return locations.
- The article recommends establishing how reactive or positive results will be communicated and arranging prompt onward referral to sexual health or infectious diseases services.
Monitoring & Follow-up
- The article recommends recording that HIV testing was offered, including when the patient declines.
- The article recommends ensuring a process is in place for communicating reactive or positive results and onward referral.
Risks
- The article states that HIV may remain undiagnosed if testing is initiated only after a positive VZV swab result.
- The article reports that approximately 4660 people in England are estimated to have undiagnosed HIV and that around 42% of new diagnoses occur late, after CD4 counts have fallen.
- The article says severe or atypical ocular complications may prompt suspicion of underlying immunosuppression.
Patient & Prescribing Data
Patients presenting with suspected HZO or VZV keratitis; the authors recommend offering testing regardless of age.
The article describes HIV testing as a routine investigation any clinician can offer and request after a brief explanation, with an opportunity for the patient to opt out. It recommends recording offers and declines and arranging communication and referral pathways for reactive or positive results.
Clinical Best Practices
- Offer HIV testing at the initial appointment when HZO or VZV keratitis is suspected rather than waiting for a positive VZV result.
- Treat collection of a VZV swab as a prompt to offer HIV testing.
- Explain why the test is being requested; the article states that extensive counselling or specialist expertise is unnecessary.
- Use local testing and result-return pathways and ensure prompt onward referral for reactive or positive results.
- Document whether testing was offered and whether it was declined.
Related Resources & Content
- HIV Indicator Diseases across Europe (HIDES) framework [1]
- NICE guideline NG60 [3]
- Foundational ophthalmic series of 112 patients with HZO [4]
Based on findings from:
Routine HIV testing in zoster eye disease
Ahmed Bakr, Navid Hakim, Paul Hine, Nardine Menassa, Nima Ghadiri. Eye, 2026.
https://www.nature.com/articles/s41433-026-05042-7
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.